Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Meningeal Carcinomatosis 2Brain Neoplasms 2Thoracic Neoplasms 1Stomach Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Extranodal NK-T-Cell 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

spartalizumab 2tislelizumab 1pegaspargase 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Oxaliplatin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Lymphoma, Extranodal NK-T-Cell × Radiotherapy, Intensity-Modulated × Clear all
NCT02276248 2017-08-16

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

ChineseAMS

Phase 2 Completed
40 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡